S
Market Data
$16.10−$2.05 (−11.27%)
SMMT · Last trade
Prev Close
$18.14
Range (29d)
$16.06 – $19.68
Recent Filings
- 8-K5.8 MBSummit Therapeutics Inc.Jan 12, 7:43 AM ET·0001599298-26-000004
- 8-K2.1 MBSummit Therapeutics Inc.Nov 7, 9:23 AM ET·0001599298-25-000166
- 8-K502.6 KBSummit Therapeutics Inc.Oct 22, 8:56 AM ET·0001193125-25-245790
- 10-Q5.6 MBSummit Therapeutics Inc.Oct 20, 7:51 AM ET·0001599298-25-000159
- 8-K12.4 MBSummit Therapeutics Inc.Oct 20, 7:28 AM ET·0001599298-25-000156
- 8-K5.9 MBSummit Therapeutics Inc.Sep 8, 7:45 AM ET·0001599298-25-000137
- 8-K3.8 MBSummit Therapeutics Inc.Aug 11, 5:13 PM ET·0001599298-25-000128
- 8-K508.3 KBSummit Therapeutics Inc.Aug 11, 4:51 PM ET·0001193125-25-178022
- 10-Q31.6 MBSummit Therapeutics Inc.Aug 11, 4:23 PM ET·0001599298-25-000126
- 8-K170.6 KBSummit Therapeutics Inc.Jun 20, 5:07 PM ET·0001599298-25-000120
Insiders
10- Anand BhaskarChief Accounting Officer
- Booth Robert F.Director
- Cesano AlessandraDirector
- Clark Kenneth ADirector
- Dhingra AnkurChief Financial Officer
- Donaldson Michael PaulChief Financial Officer
- DUGGAN ROBERT WDirector, Co-Chief Executive Officer, 10% Owner
- Erdtmann Rainer MDirector
- Gayko UrteDirector
- Graham CamillaChief Clinical Affairs Officer
Tickers
Addresses
business
601 BRICKELL KEY DRIVE SUITE 1000
MIAMI, FL, 33131
mailing
601 BRICKELL KEY DRIVE SUITE 1000
MIAMI, FL, 33131
Former Names
- Summit Therapeutics plc2020-09-17
- Summit Corp plc2015-01-30